Free Trial

Bone Biologics (BBLG) Earnings Date, Estimates & Call Transcripts

Bone Biologics logo
$1.36 +0.06 (+4.62%)
(As of 11/8/2024 ET)

Bone Biologics Latest Earnings Summary

Upcoming
Earnings Date
Nov. 12Estimated
Actual EPS
(Aug. 9)
-$0.67 Beat By $0.72
Consensus EPS
(Aug. 9)
-$1.39

Bone Biologics released Q2 2024 earnings on August 9, 2024, reporting an EPS of -$0.67, which topped analysts' consensus estimates of -$1.39 by $0.72. With a trailing EPS of $0.00, Bone Biologics' earnings are expected to grow next year, from ($3.17) to ($2.19) per share.

BBLG Upcoming Earnings

Bone Biologics' next earnings date is estimated for Tuesday, November 12, 2024, based off prior year's reporting schedules.

Get Bone Biologics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Bone Biologics and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

BBLG Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

BBLG Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Bone Biologics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241-$0.95-$0.95-$0.95
Q2 20241-$0.94-$0.94-$0.94
Q3 20241-$0.60-$0.60-$0.60
Q4 20241-$0.59-$0.59-$0.59
FY 20244-$3.08-$3.08-$3.08
Q1 20251-$0.54-$0.54-$0.54
Q2 20251-$0.51-$0.51-$0.51
Q3 20251-$0.55-$0.55-$0.55
Q4 20251-$0.59-$0.59-$0.59
FY 20254($2.19)($2.19)($2.19)

Bone Biologics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
11/12/2024
(Estimated)
------- 
8/9/2024--$1.39-$0.67+$0.72-$0.67--
5/14/2024Q1 2024-$7.60-$1.31+$6.29-$1.31--
11/14/2023Q3 2023-$24.32-$4.88+$19.44-$0.61--
8/14/2023Q2 2023-$12.00-$13.52 -$1.52-$1.69--
5/15/2023Q1 2023-$360.40-$55.28+$305.12-$6.91--
3/30/2023Q4 2022-$24.00+$24.00$3.00--
11/14/2022Q3 2022-$60.08-$28.80+$31.28-$3.60--

Bone Biologics Earnings - Frequently Asked Questions

Bone Biologics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 12th, 2024 based off last year's report dates. Learn more on BBLG's earnings history.

In the previous quarter, Bone Biologics (NASDAQ:BBLG) reported ($0.67) earnings per share (EPS) to beat the analysts' consensus estimate of ($1.39) by $0.72. Learn more on analysts' earnings estimate vs. BBLG's actual earnings.

Bone Biologics (NASDAQ:BBLG) has a recorded net income of -$8.95 million. BBLG has generated $0.00 earnings per share over the last four quarters.

Bone Biologics's earnings are expected to grow from ($3.17) per share to ($2.19) per share in the next year.

`

More Earnings Resources from MarketBeat



This page (NASDAQ:BBLG) was last updated on 11/10/2024 by MarketBeat.com Staff
From Our Partners